GMAsia
    🇨🇳China·AI News·24 Sept 2026·via SCMP·Covered by 4 sources

    China’s humanoid robot IPO slowdown no threat to firms with ‘genuine strength’: Deloitte

    Beijing is tightening initial public offering (IPO) approvals for humanoid robot makers. Deloitte China states this poses no threat to firms with clear commercialization strategies. Funding channels remain open for qualified players. Dick Kay, Deloitte China's capital market services group national leader, noted a shift from "blind rush" to "fine screening" in market funds. Investors now prioritize sustainable revenue growth, core technological barriers, and real-world application scenarios.

    Nexa's Summary

    Deloitte China's assessment clarifies Beijing's IPO tightening for humanoid robot makers. The move is not a sector shutdown. It reflects a maturing investment landscape. Funds now flow to companies with clear commercialization strategies, sustainable revenue, and core technological barriers. This points to a focus on quality over quantity in China's AI investment.

    This focus on "fine screening" benefits established Chinese players like Unitree Robotics and Agility Robotics. These firms already demonstrate advanced capabilities and clearer market pathways. Smaller, less differentiated startups will struggle to secure funding. The test for China's regulators is to balance innovation support with market stability, avoiding a speculative bubble.

    The thing to watch is how quickly new, genuinely innovative humanoid robot companies emerge and secure private funding. If private investment continues to flow to these firms, Deloitte's view holds. A sustained decline in early-stage funding would challenge the idea that "funding channels remain wide open" for all qualified players.

    Original reporting by SCMPWe don't republish, read the full story →

    Related reading

    6 stories